 |
humanized IgG4 monoclonal antibody to Toll-Like Receptor 2 (TLR2) |
|---|---|
| Trade Name | |
| Orphan Indication | Myelodysplastic syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-30 00:00:00 |
| Sponsor | Opsona Therapeutics Ltd.;2nd Floor Ashford House, Dublin 2; |
